(1R,5S)-3-azabicyclo[3.2.1]octane hydrochloride, 95.0%, 1g

(2,3-Dichloro-4-methoxyphenyl)boronic acid, 95.0%, 1g

tert-Butyl 3-((tert-butyldimethylsilyl)oxy)-5-oxopiperidine-1-carboxylate, 97%, 100mg

(2E)-1-(2-methylphenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

[(4-nitrobenzyl)thio]acetic acid, 95.0%, 1g

(1R,2S)-1-PHENYL-2-PYRROLIDIN-1-YL-PROPAN-1-OL, 97.0%, 5g

Methyl 4-(piperidin-4-yl)benzoate hydrochloride, 95.0%, 10g

Methyl 5-((tert-butoxycarbonyl)amino)thiophene-2-carboxylate, 98%, 250mg

tert-Butyl (3-aminopyridin-2-yl)carbamate, 95.0%, 250mg

(4-Amino-2-methoxyphenyl)methanol, 97%, 100mg

5-Chloroisatoic Anhydride>98.0%(HPLC)(T)5g

(2R,3S,4S,5R)-2,3,4,6-Tetrakis(benzyloxy)-5-hydroxyhexanal, 97%, 100g

Acido 5-cloro-2-nitrobenzoico, minimo 98%, per sintesi, 25 g, confezione in plastica.